Dr Christopher Staples
Senior Lecturer in Biomedical Sciences (Cancer Biology)
Qualifications
- PhD: Regulation of MAP kinase phosphatases
 University of Dundee, 2006–2010
Teaching and Supervision
Teaching Credits
MSE-3016 Pathophysiology (10 credits) - Module Organiser
MSE-2025 Molecular Biology and Biochemistry (10 credits)
MSE-3013 Third Year Research Project
MSE-4025 Dissertation
Teaching and Supervision Roles
Undergraduate project/dissertation supervision. Supervision of PhD, MSc and MRes students.
Other roles
College representative on Research Concordat Committee
External and internal viva voce examiner
Teaching and Scholarship Awards
PGCertHE Stage 1 (2017)
PGCertHE Stage 2 (2018)
Fellow of the Higher Education Academy (HEA)
Research Interests
Work in the Staples laboratory focuses largely on the characterisation of novel genome stability factors. Genome instability and DNA damage are central pathogenic mechanisms involved in cancer predisposition, premature ageing and neurodegeneration. Indeed, some cancer therapies target cancer-specific defects in DNA repair or replication fork protection mechanisms, and as such a complete understanding of such mechanisms is a major asset in the fight against cancer.
We have identified several novel DNA repair and replication fork protection factors, and our aim is to gain mechanistic insight into the function of these largely unstudied proteins with the ultimate goal of using this knowledge to design novel cancer therapies and/or predict therapeutic response.
Postgraduate Project Opportunities
Publications
2024
- PublishedAssessment of DNA fibers to track replication dynamics
 Bennett, L. G. & Staples, C. J., 13 Feb 2024, In: Methods in cell biology. 182, p. 285-298 14 p.
 Research output: Contribution to journal › Article › peer-review
- PublishedMRNIP limits ssDNA gaps during replication stress
 Bennett, L., Vernon, E., Thanendran, V., Jones, C., Gamble, A. & Staples, C., 12 Aug 2024, In: Nucleic Acids Research. 52, 14
 Research output: Contribution to journal › Article › peer-review
2023
- PublishedCDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence
 Crozier, L., Foy, R., adib, R., Kar, A., Holt, J., Pareri, A., Valverde, J., Riviera, R., Weston, W., Wilson, R., Regnault, C., Whitfield, P., Badonyi, M., Bennett, L., Vernon, E., Gamble, A., Marsh, J., Staples, C., Saurin, A. & Barr, A. & 1 others, Ly, T., 16 Nov 2023, In: Molecular Cell. 83, 22, p. 4062-4077 15 p.
 Research output: Contribution to journal › Article › peer-review
- PublishedRuthenium(II) Polypyridyl Complexes as FRET Donors: Structure- and Sequence-Selective DNA-Binding and Anticancer Properties
 Elgar, C. E., Yusoh, N. A., Tiley, P. R., Kolozsvári, N., Bennett, L., Gamble, A., Péan, E. V., Davies, M. L., Staples, C., Ahmad, H. & Gill, M. R., 18 Jan 2023, In: Journal of the American Chemical Society. 145, 2, p. 1236-1246 11 p.
 Research output: Contribution to journal › Article › peer-review
2020
- PublishedMRNIP is a replication fork protection factor
 Bennett, L., Wilkie, A., Antonopoulou, E., Ceppi, I., Sanchez, A., Vernon, E., Gamble, A., Myers, K. N., Collis, S. J., Cejka, P. & Staples, C., 10 Jul 2020, In: Science Advances. 6, 28, 10 p., eaba5974.
 Research output: Contribution to journal › Article › peer-review
2017
- PublishedApproaches for Identifying Novel Targets in Precision Medicine: Lessons from DNA Repair
 Williams, D. T. & Staples, C., 25 Aug 2017, Personalised Medicine. El-Khamisy, S. (ed.). Springer, Vol. 1007. p. 1-16 16 p. (Advances in Experimental Medicine and Biology).
 Research output: Chapter in Book/Report/Conference proceeding › Chapter
2016
- PublishedHuman CDK18 promotes replication stress signaling and genome stability
 Barone, G., Staples, C. J., Ganesh, A., Patterson, K. W., Bryne, D. P., Myers, K. N., Patil, A. A., Eyers, C. E., Maslen, S., Skehel, J. M., Eyers, P. A. & Collis, S. J., 14 Oct 2016, In: Nucleic Acids Research. 44, 18, p. 8772-8785 14 p.
 Research output: Contribution to journal › Article › peer-review
- PublishedMRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response
 Staples, C. J., Barone, G., Myers, K. N., Ganesh, A., Gibbs-Seymour, I., Patil, A. A., Beveridge, R. D., Daye, C., Beniston, R., Maslen, S., Ahel, I., Skehel, J. M. & Collis, S. J., 6 Sept 2016, In: Cell. 16, 10, p. 2565-75 11 p.
 Research output: Contribution to journal › Article › peer-review
- PublishedThe bornavirus-derived human protein EBLN1 promotes efficient cell cycle transit, microtubule organisation and genome stability
 Myers, K. N., Barone, G., Ganesh, A., Staples, C. J., Howard, A. E., Beveridge, R. D., Maslen, S., Skehel, J. M. & Collis, S. J., 14 Oct 2016, In: Scientific Reports. 6, p. 35548
 Research output: Contribution to journal › Article › peer-review
2014
- PublishedCcdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stability
 Staples, C. J., Myers, K. N., Beveridge, R. D., Patil, A. A., Howard, A. E., Barone, G., Lee, A. J., Swanton, C., Howell, M., Maslen, S., Skehel, J. M., Boutlon, S. J. & Collis, S. J., 1 Jul 2014, In: Journal of Cell Science. 127, p. 2910-2919
 Research output: Contribution to journal › Article › peer-review
- PublishedThe leukemia-associated Rho guanine nucleotide exchange factor LARG is required for efficient replication stress signaling
 Beveridge, R. D., Staples, C. J., Patil, A. A., Myers, K. N., Maslen, S., Skehel, J. M., Boulton, S. J. & Collis, S. J., 29 Oct 2014, In: Cell Cycle. 13, 21, p. 3450-3459
 Research output: Contribution to journal › Article › peer-review
2011
- PublishedPhosphorylation of the kinase interaction motif in mitogen-activated protein (MAP) kinase phosphatase-4 mediates cross-talk between protein kinase A and MAP kinase signaling pathways
 Dickinson, R. J., Delavaine, L., Cejudo-Marín, R., Stewart, G., Staples, C. J., Didmon, M. P., Trinidad, A. G., Alonso, A., Pulido, R. & Keyse, S. M., 4 Nov 2011, In: Journal of Biological Chemistry. 286, 44, p. 38018-26 9 p.
 Research output: Contribution to journal › Article › peer-review
2010
- PublishedCross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation
 Staples, C. J., Owens, D. M., Maier, J. V., Cato, A. C. B. & Keyse, S. M., 20 Aug 2010, In: Journal of Biological Chemistry. 285, 34, p. 25928-40 13 p.
 Research output: Contribution to journal › Article › peer-review
2009
- PublishedRegulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK
 Kucharska, A., Rushworth, L. K., Staples, C., Morrice, N. A. & Keyse, S. M., Dec 2009, In: Cellular Signalling. 21, 12, p. 1794-805 12 p.
 Research output: Contribution to journal › Article › peer-review
2008
- PublishedNegative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter
 Ekerot, M., Stavridis, M. P., Delavaine, L., Mitchell, M. P., Staples, C., Owens, D. M., Keenan, I. D., Dickinson, R. J., Storey, K. G. & Keyse, S. M., 1 Jun 2008, In: Biochemical Journal. 412, 2, p. 287-98 12 p.
 Research output: Contribution to journal › Article › peer-review
2007
- PublishedBiophysical properties of salmonid alphaviruses: influence of temperature and pH on virus survival
 Graham, D. A., Staples, C., Wilson, C. J., Jewhurst, H., Cherry, K., Gordon, A. & Rowley, H. M., Sept 2007, In: Journal of Fish Biology. 30, 9, p. 533-43 11 p.
 Research output: Contribution to journal › Article › peer-review
Activities
2022
- BU-IIA Funded Project: Drug Target in Pancreatic CancerThere is an urgent requirement to identify specific, precision medicine drug targets that selectively kill PDACs with mutations in BRCA2 and other DNA repair factors, or which sensitise them further to existing treatments. We are therefore applying for funding to develop CRISPR-Cas9 dropout screening at Bangor –a powerful technique for identifying novel precision medicine drug targets in cancer cells. While our initial focus is on PDAC, once in place this methodology can be applied to drive the discovery of drug targets for a wide array of human diseases. Funding awarded through the Bangor University Innovation and Impact Award (Research Wales Innovation Funding). Value = £49,466 1 Apr 2022 – 31 Mar 2023 Activity: Other (Contributor)
2021
- BBSRC reviewer20 Jun 2021 Activity: Types of External academic engagement - Contribution to the work of national or international committees and working groups (Contributor)
- The Role of HERC2 in CiliogenesisInvited talk at the 26th UK Cilia Network Symposium 17 May 2021 Activity: Oral presentation (Speaker)
- NWCR Scientific Committee MembershipMember of scientific panel 9 May 2021 → Activity: Types of External academic engagement - Contribution to the work of national or international committees and working groups (Contributor)
- Peer reviewer for the Humane Research Trust9 May 2021 Activity: Types of External academic engagement - Contribution to the work of national or international committees and working groups (Contributor)
2020
- DNA Repair (Journal)Peer reviewer 7 Nov 2020 Activity: Publication peer-review (Editorial board member)
- Peer-reviewer for UKRI Future Leaders FellowshipsPeer-reviewer for UKRI Future Leaders Fellowships 25 Oct 2020 Activity: Types of External academic engagement - Contribution to the work of national or international committees and working groups (Contributor)
- Molecular Oncology (Journal)Peer review 11 Sep 2020 Activity: Publication peer-review (Editorial board member)
- BBSRC Peer ReviewReviewed a BBSRC Responsive Mode Application 31 Aug 2020 Activity: Types of External academic engagement - Contribution to the work of national or international committees and working groups (Contributor)
- Internal Examiner for PhD Viva21 Apr 2020 Activity: Examination (Examiner)
- Chair for PhD Viva2 Apr 2020 Activity: Examination (Examiner)
- Peer reviewProvided peer review for a BBSRC project grant application 4 Mar 2020 Activity: Types of External academic engagement - Contribution to the work of national or international committees and working groups (Contributor)
- PLoS Biology (Journal)Acted as peer reviewer 7 Jan 2020 Activity: Publication peer-review (Editorial board member)
2019
- External examiner for PhD candidate in LancasterSupervised by Nikki Copeland 13 Jun 2019 Activity: Examination (Examiner)
- Examined Prof Ciaran Morrisons PhD student (Galway)External examiner 4 Jun 2019 Activity: Examination (Examiner)
- MRNIP is a novel replication fork protection factor15 min talk at international conference 2019 Activity: Oral presentation (Speaker)
2018
- Novel players in replication fork protectionInvited speaker to research seminar series 18 Mar 2018 Activity: Oral presentation (Speaker)
- External examiner for MRes viva29 Jan 2018 Activity: Examination (Examiner)
2017
- Internal Examiner for PhD viva9 Nov 2017 Activity: Examination (Examiner)
- The role of MRNIP in DNA repairInvited speaker to research seminar series 11 May 2017 Activity: Oral presentation (Speaker)
Projects
- 
New radiosensitizers for triple-negative breast cancer 01/07/2024 – 15/07/2027 (Active) 
- 
Daughter Strand Gaps as determinants of chemoresistance 03/06/2024 – 30/06/2026 (Active) 
- 
A novel role for the innate immune sensor IFI16 in the cancer cell response to chemotherapy 01/01/2024 – 31/03/2028 (Active) 
- 
Regulation of chemosensitivity by the novel daughter strand gap suppressor MRNIP 01/12/2023 – 15/12/2026 (Active) 
- 
01/10/2023 – 30/11/2026 (Active) 
- 
Wales Cancer Research Centre / Overcoming breast cancer resistance to CDK4/6 inhibitors.' 01/04/2023 – 15/04/2025 (Finished) 
- 
Daughter strand gaps as crucial determinants of therapeutic response 01/10/2022 – 31/12/2025 (Active) 
- 
KESS II MRes with NWCR - BUK2E089 01/10/2022 – 31/03/2024 (Finished) 
- 
KESS II MRes with BEE Robotics BUK2E081 01/07/2022 – 31/03/2024 (Finished) 
- 
HEFCW HEIR COVID extension to UKRI FLF MRC bid (F008177, R49R01, MR/S034579/1) 01/05/2021 – 31/08/2021 (Finished) 
- 
KESS II MRes with North West Cancer Research BUK2225 01/01/2021 – 31/03/2024 (Finished) 
- 
KKESS II East Phd with North West Cancer Research BUK2E019 01/02/2020 – 29/02/2024 (Finished) 
- 
The role of MRNIP in replication fork stabilisation and DSB repair 01/12/2019 – 31/12/2023 (Finished) 
- 
Potential roles of MRNIP and IFI16 in linking oncogene-induced replication 01/07/2019 – 01/08/2022 (Finished) 
- 
Replication fork reversal and stability (UNS87415 Mr Anuj Narwal) 01/06/2019 – 01/08/2019 (Finished) 
- 
Investigation of novel regulators of genome stability 01/01/2019 – 30/06/2022 (Finished) 
- 
Autophagy dependent survival following Mec1(ATM/ATR) inactivation 01/05/2018 – 31/07/2023 (Finished) 
- 
Role of RadIP, a novel DNA repair factor in the DNA damage response to chemotherapy. 01/11/2016 – 31/08/2020 (Finished) 
- 
Targeting CtIP to sensitise cancer cells to DNA-damaging agents 01/10/2016 – 31/07/2018 (Finished) 
- 
Therapeutically relevant novel links between DNA damage and ciliogenesis 01/10/2016 – 19/08/2023 (Finished)